$CYH SEC Filings

Filed On	Filing
28 Oct 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
25 Aug 2026	Form 4: Jennings William Norris, Director Sold 40,000 shares ($118K)
25 Aug 2026	144
10 Aug 2026	SCHEDULE 13G/A
23 Jul 2026	10-Q
22 Jul 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
30 Jun 2026	Form 4: Krishnan K Ranga, Director Received 13,930 shares by exercise or conversion
01 Jun 2026	Form 4: Rice David V., EVP-Clinical Operations & CMO Received 30,000 shares as a grant or award · Granted 30,000 Performance Based Restricted · Granted 30,000 Stock Options (Right to Buy)
01 Jun 2026	8-K: Completion of Acquisition or Disposition of Assets; Other Events
15 May 2026	SCHEDULE 13G/A
15 May 2026	SCHEDULE 13G/A
14 May 2026	Form 3: Rice David V., EVP-Clinical Operations & CMO No securities owned
14 May 2026	SCHEDULE 13G
13 May 2026	8-K: Submission of Matters to a Vote of Security Holders
06 May 2026	8-K: Other Events
23 Apr 2026	8-K: Other Events
22 Apr 2026	Form 4: Krishnan K Ranga, Director Received 46,950 shares by exercise or conversion
22 Apr 2026	10-Q
21 Apr 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
02 Apr 2026	ARS

Comments